The abstract is read at the publisher; the summary is JClub's.
eGFR after islet transplantation shows a triphasic decline, dropping fastest in year 1 (-11.52 ml min -1 1.73 m -2 per year) before slowing through years 1–5 and 5–20.
- Why it matters: Calcineurin inhibitor immunosuppression is linked to nephrotoxicity, but long-term kidney trajectories and which recipients progress to stage 3b CKD are not well defined.
- What they did: In 223 adults with type 1 diabetes receiving islet transplantation at the University of Alberta Hospital (1999–2018), mixed-effects models estimated eGFR decline rates and Cox/competing-risk models predicted progression to stage 3b CKD (eGFR <45 ml min -1 1.73 m -2).
- The result: Stage 3b CKD occurred in 21% (47/222) over a median 6.4 years; female sex (sub-distribution HR 2.17; p=0.017) and lower baseline eGFR (sub-distribution HR 0.96 per ml min -1 1.73 m -2; p=0.0009) predicted progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.